News Overview

Maruti Suzuki India Limited has informed the Exchange about press release dated 18-Nov-2022 titled India???s favourite hatchback, All-New Alto K10 now available with S-CNG technology

Mcnally Bharat Engineering Company Limited has informed the Exchange about Minutes of Annual General Meeting held on 07-Sep-2022

Sun Pharma Advanced Research Company Limited has informed the Exchange about press release dated 18-Nov-2022 titled Press Release: SEZABY TM (phenobarbital sodium powder for injection) approved by US FDA for the treatment of neonatal seizures

Aurobindo Pharma Limited is pleased to announce that its wholly owned subsidiary company, Eugia Pharma Specialities Limited, has received a final approval from the US Food & Drug Administration (USFDA) for Amphotericin B Liposome for Injection, 50 mg. Amphotericin B Liposome for Injection, 50 mg/vial Single-Dose Vial to be bioequivalent and therapeutically equivalent to the reference listed drug (RLD), AmBisome Liposome for Injection, 50 mg/vial, of Astellas Pharma US, Inc.. The product is expected to be launched by Q4 FY23. The approved product has an estimated market size of around US$ 145 million for the twelve months ending September 2022, according to IQVIA.

PTC India Financial Services Limited has informed the Exchange about Investor Presentation

Muthoot Capital Services Limited has informed the Exchange about appointment of Ramandeep Singh Gill as Chief Financial Officer of the company w.e.f. 06-Dec-2022.

LTIMindtree Limited has informed the Exchange about press release dated 18-Nov-2022 titled LTIMindtree Inaugurates Digital Experience Centre in Hyderabad

PAGEIND : The Exchange has sought clarification from Page Industries Limited with respect to recent news item captioned Page Industries to invest Rs 290 cr to set up two facilities in Telangana. The response from the Company is attached.

SBIN : The Exchange has sought clarification from State Bank Of India with respect to recent news item captioned SBI signs Rs 1,240-cr loan agreement with Germanys KfW for solar projects. The response from the Company is attached.

Strides Pharma Science Limited has informed the Exchange about press release dated 18-Nov-2022 titled Strides receives USFDA approval for Potassium Chloride Oral Solution